18th June 2020
| General News
Properties of an Ideal Hemostatic Agent Hemorrhage control is vital for clinical outcome after surgical treatment and for traumatic injuries. Here is a summary of the properties of an ideal...
8th June 2020
| General News, Hemostat News
Part 1 – Introduction Celox Gauze has been incorporated into the Tactical Combat Casualty Care Guidelines as a hemostat of choice for multiple military forces and first aid responders units...
18th March 2020
| General News
According to the Centers for Disease Control (CDC) and Prevention there are 3 million people that are affected by bleeding disorders. Some bleeding disorders are inherited such as Hemophilia A...
13th January 2020
| General News
According to a 2018 review by the New England Journal of Medicine about 60,000 Americans die from uncontrolled hemorrhage or blood loss.1 Hemorrhage can often be preventable when equipped with...
29th July 2019
| General News, Hemostat News
Omni-stat Medical Inc was recently established in 2018 to provide a solution to bleeding control in a hospital setting. OMNI-STAT® is made of a proprietary composition which contains chitosan in...
5th March 2019
| General NewsOmni-stat Medical Inc is pleased to welcome Chad Yount to the recently established US company with focus on providing proprietary hemostatic agents based on chitosan technology to the US hospital...
Omni-stat Medical Inc
New York – SoHo – Hudson Square,
101 Avenue of the Americas,
8th and 9th Floors,
New York, NY 10013,
USA
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
This website uses Cookies to improve your browsing experience. View Cookies Policy
I'm fine with this